periodont
diseas
common
infect
characteris
chronic
inflamm
periodont
periodont
diseas
affect
dog
proport
increas
dog
older
year
periodont
diseas
caus
format
biofilm
due
growth
bacteria
gingiv
biofilm
elicit
abnorm
host
immun
respons
follow
destruct
periodont
tissu
periodont
ligament
alveolar
bone
eventu
lead
tooth
among
periodont
pathogen
porphyromona
gula
bacteri
speci
often
associ
periodont
diseas
fima
fimbria
express
cell
surfac
strain
p
gula
bacteria
obtain
fima
protein
divid
three
genotyp
b
c
base
differ
put
amino
acid
among
fima
genotyp
type
c
p
gula
consid
virul
predomin
oral
caviti
dog
sever
interestingli
type
c
p
gula
also
preval
oral
caviti
dog
mitral
impli
p
gula
may
associ
type
system
diseas
periodont
pathogen
disrupt
host
innat
immun
respons
result
exacerb
periodont
notabl
overexpress
transform
growth
gingiv
cell
close
relat
periodont
tissu
thu
method
control
inflammatori
respons
elimin
periodont
bacteria
consid
import
inhibit
periodont
diseas
classifi
type
interferon
gener
secret
combat
also
produc
pharmaceut
agent
use
treatment
autoimmun
infecti
diseas
addit
canin
formul
hokusan
co
ltd
higashihiroshima
japan
commerci
avail
pharmaceut
agent
periodont
treatment
anim
sinc
administr
canin
formul
oral
caviti
dog
report
improv
gingiv
symptom
reduc
number
bacteria
porphyromona
howev
studi
focus
role
treatment
periodont
diseas
dog
recommend
approach
prevent
treatment
periodont
diseas
involv
mainten
oral
hygien
owner
profession
periodont
treatment
antibiot
gener
prescrib
combin
periodont
treatment
scale
root
plane
aim
reduc
number
pathogen
addit
use
antibiot
periodont
recoveri
reli
control
inflammatori
respons
within
infect
periodont
therefor
method
capabl
suppress
host
inflammatori
immun
system
develop
use
periodont
treatment
addit
combin
applic
antibiot
medic
profession
periodont
treatment
howev
efficaci
antiinflammatori
treatment
periodont
tissu
infect
p
gula
yet
investig
present
studi
analys
inhibitori
effect
clindamycin
antibiot
frequent
use
periodont
treatment
dog
growth
p
gula
strain
accord
fima
genotyp
addit
studi
investig
whether
formul
could
inhibit
overexpress
inflammatori
respons
gingiv
epitheli
cell
induc
p
gula
infect
final
studi
analys
effect
combin
treatment
clindamycin
formul
periodont
condit
level
p
gula
fima
genotyp
present
within
oral
specimen
dog
clindamycin
use
treatment
periodont
diseas
therefor
analys
whether
clindamycin
effect
p
gula
fima
genotyp
growth
p
gula
strain
test
fima
genotyp
b
c
significantli
reduc
presenc
clindamycin
compar
growth
without
clindamycin
p
fig
clindamycin
inhibit
bacteri
growth
p
gula
strain
dosedepend
manner
inhibitori
effect
p
gula
type
c
significantli
greater
p
gula
atcc
type
p
gula
type
b
presenc
concentr
clindamycin
p
inhibitori
effect
p
gula
type
b
significantli
greater
p
gula
atcc
type
presenc
clindamycin
bacteri
growth
p
gula
analys
presenc
formul
concentr
formul
show
effect
growth
p
gula
fig
addit
effect
clindamycin
growth
p
gula
inhibit
use
formul
p
gingivali
speci
close
relat
p
gula
induc
inflammatori
disord
caus
aggrav
periodont
gingiv
epitheli
cell
play
import
role
prevent
bacteri
invas
deeper
howev
chang
host
inflammatori
respons
produc
gingiv
epitheli
cell
expos
p
gula
remain
unknown
rel
ratio
mrna
express
level
human
gingiv
epitheli
cell
infect
p
gula
strain
analys
respect
level
h
p
gula
infect
defin
level
presenc
p
gula
strain
highest
h
infect
level
significantli
higher
uninfect
cell
p
supplementari
fig
addit
h
infect
express
induc
p
gula
type
c
infect
significantli
higher
induc
p
gula
atcc
type
p
gula
type
b
p
similar
trend
observ
respect
express
tend
higher
presenc
strain
type
c
presenc
strain
atcc
type
type
b
howev
signific
differ
among
strain
chang
express
level
time
p
gula
infect
subsequ
measur
protein
level
p
gulaeinfect
cell
fig
cell
infect
strain
bacteria
increas
protein
level
observ
wherea
protein
express
nearli
absent
regardless
presenc
bacteria
similar
mrna
analysi
express
level
induc
strain
type
c
infect
significantli
higher
express
level
induc
strain
atcc
type
type
b
report
effect
chronic
infecti
oral
administr
formul
improv
gingiv
inflamm
dog
periodont
therefor
p
gula
strain
formul
simultan
ad
respect
cultur
cell
express
level
analys
h
incub
experi
formul
clindamycin
combin
treatment
formul
clindamycin
confirm
effect
growth
uninfect
cell
supplementari
fig
b
treatment
formul
significantli
reduc
mrna
express
level
protein
product
level
cell
infect
p
gula
atcc
type
p
gula
type
b
respect
p
chang
express
observ
supplementari
fig
fig
addit
chang
express
level
observ
cell
infect
p
gula
type
c
schedul
treatment
summar
fig
fiftytwo
dog
divid
four
group
without
pharmaceut
treatment
follow
pharmaceut
treatment
control
group
n
clindamycin
treatment
clindamycin
group
n
formul
treatment
group
n
clindamycin
formul
combin
treatment
combin
group
n
tabl
clindamycin
group
clindamycin
ingest
total
day
day
day
scale
group
formul
hokusan
co
ltd
appli
gingiv
margin
teeth
time
total
day
gingiv
periodont
score
dog
assess
begin
end
clinic
treatment
accord
previous
describ
periodont
score
group
treatment
significantli
lower
treatment
p
fig
addit
rel
ratio
calcul
periodont
score
periodont
treatment
compar
periodont
treatment
combin
group
lowest
rel
ratio
although
signific
differ
among
group
fig
shown
fig
accumul
dental
plaqu
dental
calculu
around
teeth
reduc
gingiv
condit
improv
periodont
treatment
combin
group
oral
swab
specimen
collect
gingiv
margin
maxillari
right
left
canin
fourth
maxillari
premolar
begin
end
clinic
treatment
describ
distribut
p
gula
fima
genotyp
classif
oral
specimen
determin
use
polymeras
chain
reaction
pcr
base
method
previous
except
two
dog
control
group
dog
posit
p
gula
periodont
treatment
p
gulaeposit
dog
control
group
posit
p
gula
treatment
tabl
fig
two
dog
clindamycin
group
four
dog
group
neg
p
gula
treatment
combin
group
lowest
rate
p
gula
detect
treatment
p
gula
absent
oral
caviti
six
dog
next
determin
rel
ratio
detect
fima
type
treatment
compar
treatment
control
group
rel
ratio
fima
type
b
reduc
treatment
fig
contrast
rel
ratio
fima
type
c
reduc
treatment
clindamycin
group
rel
ratio
fima
genotyp
reduc
treatment
combin
group
notabl
rel
ratio
fima
type
c
dramat
reduc
treatment
present
dog
clindamycin
combin
group
respect
detect
rate
fima
genotyp
group
compar
control
group
detect
rate
fima
genotyp
group
except
fima
type
b
clindamycin
group
lower
control
group
periodont
diseas
inflammatori
diseas
caus
bacteri
bacteri
plaqu
remain
gingiv
sulcu
teeth
gingiva
result
gingiv
margin
gingiva
becom
red
presenc
chronic
gingiv
result
format
irrevers
deep
periodont
pocket
gingiv
consequ
alveolar
bone
resorpt
tooth
mobil
occur
follow
loss
teeth
periodont
diseas
present
matur
dog
one
preval
diseas
p
gula
major
periodontopath
bacteria
strongli
associ
deterior
periodont
diseas
howev
studi
potenti
prevent
periodont
diseas
dog
reduc
pathogen
p
gula
present
studi
examin
inhibit
p
gula
periodont
diseas
use
treatment
clindamycin
formul
antibacteri
agent
often
prescrib
period
week
combin
periodont
treatment
approach
use
reduct
periodont
among
antibiot
prescrib
scale
root
plane
treatment
dog
lincomycinderiv
antibacteri
agent
clindamycin
wide
use
prevent
present
studi
clindamycin
use
assess
inhibitori
effect
antibiot
treatment
growth
p
gula
low
concentr
clindamycin
could
inhibit
growth
fima
type
p
gula
among
inhibitori
effect
promin
affect
type
c
p
gula
strain
clinic
portion
studi
type
c
p
gula
also
reduc
dog
receiv
clindamycin
treatment
previou
studi
type
c
p
gula
frequent
detect
dog
periodont
rate
significantli
higher
healthi
therefor
clindamycin
may
especi
effect
dog
sever
periodont
cell
line
use
vitro
counterpart
gingiv
epitheli
bacteri
compon
chemic
regent
previous
report
induc
sever
inflammatori
respons
addit
mrna
express
level
sever
cell
line
reportedli
upregul
exposur
viru
proteas
although
level
mrna
thu
examin
effect
p
gula
infect
rapidli
emerg
key
player
regul
inflammatori
process
capabl
augment
addit
exhibit
import
role
modul
inflammatori
cytokin
human
gingiv
epitheli
cell
infect
p
key
enzym
involv
prostaglandin
synthesi
express
inflammatori
also
known
potent
stimul
bone
resorpt
associ
periodont
attach
key
player
inflammatori
condit
potent
neutrophil
recruit
activ
induc
gingiv
epitheli
cell
upon
exposur
sever
type
periodontopath
shown
play
critic
role
antiinflammatori
occur
wound
heal
periodont
result
indic
p
gula
infect
induc
overexpress
potenti
lead
inflamm
involv
deterior
periodont
diseas
sever
oral
pathogen
fusobacterium
nucleatum
streptococcu
sanguini
aggregatibact
actinomycetemcomitan
report
induc
increas
mrna
express
level
tumour
necrosi
stimul
immortalis
human
gingiv
epitheli
cell
vesicl
p
gingivali
bacteria
led
upregul
addit
stimul
p
gula
shown
induc
increas
secret
present
studi
found
secret
express
level
tumour
necrosi
increas
upon
infect
p
gula
find
suggest
p
gula
infect
induc
mrna
express
wide
varieti
inflammatoryrel
protein
cell
mrna
protein
express
reportedli
upregul
infect
bacteria
staphylococcu
aureu
helicobact
pylori
group
contrast
infect
human
gingiv
fibroblast
cell
p
gingivali
result
increas
mrna
express
level
influenc
correspond
protein
express
follow
p
gula
infect
present
studi
mrna
express
level
increas
correspond
protein
express
level
affect
suggest
effect
p
gula
express
similar
p
gingivali
moreov
find
indic
protein
express
level
may
alway
reflect
mrna
express
level
pharmaceut
agent
contain
wide
use
antivir
anticanc
agent
inhibit
growth
virus
cancer
addit
effect
regul
immun
inflammatori
therefor
examin
whether
canin
formul
could
suppress
inflammatori
respons
gingiv
epitheli
cell
infect
p
gula
found
formul
could
reduc
express
upregul
infect
fima
type
b
p
gula
strain
furthermor
found
clindamycin
effect
formul
fima
type
c
p
gula
strain
thu
combin
use
formul
clindamycin
may
effect
p
gula
strain
regardless
fima
genotyp
futur
studi
plan
analys
effect
combin
use
formul
clindamycin
express
cytokin
enzym
well
surviv
variou
periodontopathogen
bacteria
present
studi
examin
whether
formul
use
suppress
inflammatori
respons
induc
p
gula
infect
whether
may
effect
treatment
periodont
diseas
dog
appli
formul
remov
dental
plaqu
dental
calculu
allow
formul
penetr
periodont
tissu
addit
continu
applic
formul
day
suppress
chronic
inflamm
periodont
diseas
chronic
although
formul
appli
dog
durat
present
studi
durat
frequenc
formul
appli
determin
basi
periodont
diseas
sever
futur
studi
formul
use
dog
regardless
age
base
approv
ministri
agricultur
forestri
fisheri
manufactur
current
recommend
formul
administ
dog
periodont
score
howev
success
shown
formul
also
effect
dog
sever
periodont
condit
indic
formul
use
treatment
dog
sever
periodont
experiment
period
dog
problem
gingiv
physic
condit
due
administr
formul
base
result
formul
could
use
treatment
dog
variou
age
variou
degre
periodont
diseas
present
studi
periodont
score
reduc
dog
clinic
periodont
treatment
reduct
periodont
score
also
observ
control
group
serv
evid
import
mechan
remov
dental
plaqu
dental
calculu
scale
root
plane
consist
find
previou
howev
group
receiv
combin
treatment
show
lowest
periodont
score
among
group
therefor
combin
use
clindamycin
formul
may
effect
support
method
improv
periodont
condit
follow
mechan
clean
human
formul
use
periodont
treatment
howev
may
use
investig
whether
combin
treatment
antibiot
formul
effect
human
periodont
diseas
dog
owner
sometim
colon
p
gula
addit
may
also
inform
analys
whether
combin
treatment
antibiot
formul
effect
inhibit
p
gingivali
growth
bacteri
speci
detect
human
dog
periodont
diseas
best
knowledg
first
studi
show
combin
clindamycin
formul
effect
improv
periodont
condit
dog
studi
show
combin
therapi
clindamycin
could
improv
periodont
condit
reduc
p
gula
randomli
select
dog
howev
addit
effect
clindamycin
genet
environment
factor
may
influenc
find
small
number
dog
particip
studi
therefor
larger
clinic
studi
need
use
dog
differ
background
summari
clindamycin
effect
antibiot
inhibit
growth
p
gula
applic
formul
suppress
inflammatori
respons
produc
p
gulaeinfect
gingiv
epitheli
cell
combin
clindamycin
formul
treatment
canin
periodont
diseas
may
contribut
improv
periodont
condit
dog
p
gula
strain
atcc
fima
type
fima
type
b
fima
type
c
select
stock
cultur
collect
bacteri
cell
grown
anaerob
h
trypticas
soy
broth
supplement
yeast
extract
mgml
haemin
menadion
previous
use
follow
experi
cell
origin
isol
human
gingiv
epithelia
obtain
japanes
collect
research
bioresourc
tokyo
japan
cell
use
vitro
counterpart
gingiv
epitheli
wide
use
vitro
cultur
model
gingiv
epitheli
cell
cultur
dulbecco
modifi
eagl
medium
dmem
wako
osaka
japan
supplement
fetal
bovin
serum
bacteri
growth
analys
accord
previous
describ
method
variou
concentr
clindamycin
test
effect
p
gula
growth
addit
variou
concentr
formul
test
clindamycin
formul
separ
combin
ad
trypticas
soy
broth
supplement
yeast
extract
haemin
menadion
use
bacteri
suspens
growth
addit
overnight
cultur
p
gula
bacteria
ad
media
densiti
cfuml
cultur
h
bacteri
growth
incub
measur
determin
optic
densiti
nm
use
micropl
reader
lab
corona
electr
katsuta
japan
number
p
gula
bacteria
given
suspens
previous
estim
measur
optic
densiti
nm
subsequ
extrapol
standard
rel
ratio
growth
p
gula
strain
calcul
comparison
optic
densiti
nm
valu
bacteri
broth
without
clindamycin
assay
perform
triplic
three
separ
occas
n
cell
incub
dmem
fetal
bovin
serum
confluent
incub
monolay
cell
wash
three
time
serumfre
dmem
remov
unattach
cell
addit
number
viabl
cell
monolay
determin
use
trypan
blue
dye
exclus
cell
count
method
preincub
cell
prior
addit
bacteria
overnight
cultur
p
gula
harvest
wash
steril
phosphatebuff
salin
bacteria
dilut
cfuml
dmem
use
infect
cell
experi
involv
bacteri
infect
cell
use
concept
multipl
infect
moi
commonli
defin
ratio
infecti
microorgan
cell
cell
dilut
densiti
infect
cfu
respect
p
gula
strain
moi
h
total
rna
extract
p
gulaeinfect
cell
cdna
synthes
describ
briefli
total
rna
cell
isol
use
trisur
biolin
luckenwald
germani
convert
cdna
use
cdna
synthesi
kit
biorad
hercul
ca
usa
accord
manufactur
instruct
cdna
amplifi
use
quantifast
sybr
green
pcr
master
mix
qiagen
valencia
ca
usa
accord
manufactur
instruct
primer
specif
gene
encod
use
studi
list
tabl
gapdh
use
housekeep
control
neg
revers
transcript
reaction
includ
assay
express
valu
mrna
quantifi
method
use
gapdh
control
assay
perform
triplic
three
separ
occas
n
p
gula
strain
use
infect
cell
without
administr
formul
describ
section
regard
rtpcr
elisa
perform
accord
previous
describ
method
cell
stimul
p
gula
strain
presenc
absenc
h
quantif
cell
lysat
time
point
sandwich
elisa
perform
use
human
elisa
kit
proteintech
group
inc
rosemont
il
usa
humanmous
total
duoset
ic
elisa
r
system
inc
minneapoli
mn
usa
elisa
kit
proteintech
group
inc
elisa
kit
proteintech
group
inc
respect
accord
manufactur
instruct
absorb
measur
nm
correct
nm
use
lab
micropl
reader
corona
electr
ibaraki
japan
assay
perform
triplic
three
separ
occas
n
clinic
experi
conduct
full
adher
declar
helsinki
studi
protocol
approv
anim
research
committe
azabu
univers
prior
clinic
experi
owner
inform
content
studi
gave
written
inform
consent
approv
pet
particip
schedul
clinic
treatment
summar
fig
total
dog
male
femal
median
age
year
rang
year
enrol
tabl
dog
receiv
periodont
treatment
gener
anaesthesia
subject
divid
four
group
without
pharmaceut
treatment
follow
pharmaceut
treatment
control
group
n
clindamycin
treatment
clindamycin
group
n
formul
treatment
group
n
combin
clindamycin
formul
treatment
combin
group
n
clindamycin
group
clindamycin
mgkg
administ
via
oral
caviti
twice
per
day
begin
day
treatment
end
day
periodont
treatment
total
day
accord
guidelin
american
anim
hospit
group
g
formul
appli
gingiv
margin
teeth
time
total
day
periodont
treatment
combin
group
receiv
clindamycin
formul
treatment
accord
method
describ
oral
swab
specimen
collect
gingiv
margin
maxillari
right
left
canin
fourth
premolar
use
micro
brush
microappl
fine
feed
corpor
yokohama
japan
describ
sever
day
week
periodont
treatment
periodont
score
determin
assess
gingiv
margin
maxillari
right
left
canin
fourth
maxillari
premolar
sever
day
week
periodont
treatment
use
modifi
version
previous
describ
dog
gingiv
score
maxillari
right
left
canin
fourth
premolar
evalu
visual
follow
signific
find
mild
periodont
swell
gingiv
regress
halitosi
moder
periodont
root
spontan
bleed
tooth
loss
sever
periodont
involv
fistula
format
distribut
p
gula
fima
genotyp
determin
use
previous
develop
pcrbase
tabl
list
pcr
primer
use
studi
bacteri
dna
extract
oral
specimen
use
gentra
puregen
yeastbact
kit
b
qiagen
hilden
germani
pcr
analysi
perform
use
univers
primer
set
target
rrna
gene
confirm
bacteri
dna
success
extract
subsequ
p
gula
fima
genotyp
determin
use
respect
specif
primer
amplif
reaction
perform
use
total
volum
templat
solut
ex
taq
dna
polymeras
takara
bio
inc
otsu
japan
follow
cycl
paramet
initi
denatur
min
cycl
final
extens
min
amplif
reaction
perform
icycl
thermal
cycler
biorad
result
product
separ
electrophoresi
agaros
geltrisacetateedta
buffer
gel
stain
ethidium
bromid
photograph
ultraviolet
illumin
statist
analys
conduct
use
graphpad
prism
graphpad
softwar
inc
la
jolla
ca
usa
intergroup
differ
estim
use
analysi
varianc
bonferroni
correct
differ
consid
statist
signific
p
